Warren Buffett Held Wells Fargo Stock for More Than 30 Years Before Selling It. Here's the Lesson for Bank Stocks.

Berkshire Hathaway began buying Wells Fargo in 1989 and built it into a core holding, but exited in 2022 after the bank's unauthorized-account scandal, regulatory penalties and asset cap. Wells Fargo paid billions in fines and faced the seven-year cap before the Trump administration ended it in 2025; CEO Charlie Scharf also led operational and regulatory changes. The article presents the investment as a mixed case study in reputational risk and evaluating beaten-down banks with credible turnaround plans.

Analysis

The key investment variable is no longer simply whether Wells Fargo can grow its balance sheet, but whether newly available capacity can be converted into durable returns without reintroducing control failures. Removing a regulatory constraint may improve the earnings ceiling and reduce a governance discount; it does not itself prove stronger deposit gathering, loan demand, or capital-light revenue execution. Those are the operating tests.

Near term, the regulatory milestone can support sentiment, but the market may capitalize the release before incremental earnings appear. Over 1–3 months, watch management guidance and reported loan/deposit growth, expense efficiency, and capital returns for evidence that capacity is being monetized. Over 6–18 months, sustained return improvement—not the headline removal of restrictions—would justify a more durable relative re-rating. JPMorgan, Bank of America, and Citigroup could face modest competitive pressure if Wells Fargo competes more aggressively for customers, though any share shifts are likely gradual.

Contrarian read: Buffett’s exit is not proof the turnaround was uninvestable; it may reflect the unusually long and opaque regulatory timeline, a poor fit with Berkshire’s preference for predictable economics, and disagreement over execution. Conversely, the article’s favorable hindsight risks treating regulatory relief as validation of future returns. The thesis weakens if growth fails to translate into better efficiency or returns, or if new supervisory findings reveal control gaps. There is no basis here to infer Berkshire’s current view or Wells Fargo’s relative valuation.

Key Decisions for Investors

• Treat Wells Fargo as a conditional turnaround watch, not an automatic buy on regulatory relief. Verify current valuation, guidance, and post-restriction operating data before taking exposure.
• For a 1–3 month catalyst check, monitor loan and deposit growth, expense efficiency, capital-return plans, and any renewed regulatory findings. Require evidence that incremental balance-sheet capacity is producing attractive returns.
• If those metrics improve while the shares lag large U.S. bank peers, consider a measured relative-value long in Wells Fargo against a diversified bank exposure; define the thesis around relative return improvement, not simply the restriction’s removal.
• Falsify the thesis if management cannot convert capacity into sustained efficiency and return gains, or if supervisory actions indicate material control weaknesses. Avoid extrapolating the turnaround from the regulatory milestone alone.